Back to Journals » OncoTargets and Therapy » Volume 7

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity

Total article views   HTML views PDF downloads Totals
8,906 Dovepress* 7,982+ 1,336 9,318
PubMed Central* 924 325 1,249
Totals 8,906 1,661 10,567
*Since 21 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar